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Abstract
Background: Leber hereditary optic neuropathy (LHON) is a mitochondrial disorder with gender biased and
incomplete penetrance. The majority of LHON patients are caused by one of the three primary mutations (m.3460G
> A, m.11778G > A and m.14484T > C). Rare pathogenic mutations have been occasionally reported in LHON
patients.
Methods: We screened mutation m.10680G > A in the MT-ND4L gene in 774 Chinese patients with clinical
features of LHON but lacked the three primary mutations by using allele specific PCR (AS-PCR). Patients with
m.10680G > A were further determined entire mtDNA genome sequence.
Results: The optimal AS-PCR could detect as low as 10% heteroplasmy of mutation m.10680G > A. Two patients
(Le1263 and Le1330) were identified to harbor m.10680G > A. Analysis of the complete mtDNA sequences of the
probands suggested that they belonged to haplogroups B4a1 and D6a1. There was no other potentially
pathogenic mutation, except for a few private yet reported variants in the MT-ND1 and MT-ND5 genes, in the two
lineages. A search in reported mtDNA genome data set (n = 9277; excluding Chinese LHON patients) identified no
individual with m.10680G > A. Frequency of m.10680G > A in Chinese LHON patients analyzed in this study and
our previous studies (3/784) was significantly higher than that of the general populations (0/9277) (P = 0.0005).
Conclusion: Taken together, we speculated that m.10680G > A may be a rare pathogenic mutation for LHON in
Chinese. This mutation should be included in future clinical diagnosis.
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Background
Leber hereditary optic neuropathy (LHON, MIM535000)
is one of the most common mitochondrial disorders,
which mainly leads to vision loss in young males [1-3].
Three primary mutations (m.3460G > A in the MT-ND1
gene, m.11778G > A in the MT-ND4 gene, and m.14484T
>Ci nt h eMT-ND6 gene) accounted for the etiology of
more than 95% LHON patients, whereas the remaining
5% cases was caused by rare mutations and/or unclear
factors [1-3]. Up to now, there is a considerable long list
for rare mutations for LHON (cf. http://www.mitomap.
org). Most recently, m.3635G > A in the MT-ND1 gene
was confirmed to be a rare primary mutation and had a
multiple occurrence in Han Chinese and Russian LHON
families [4-7]. Clinical expression of primary LHON muta-
tion was affected by many factors including mtDNA back-
ground/haplogroups [8,9], nuclear genes [10-12] and
environmental factors [2,13]. Though more and more
LHON risk factors have been identified, there are abun-
dant suspected LHON patients without any reported
pathogenic mtDNA mutations [14,15].
In our recent study, we found mutation m.10680G > A
in a suspected LHON family lacking any known primary
mutation, and this family had a considerably high pene-
trance of disease (40%; [15]) compared with that of
families with m.11778G > A (about 33.3%; [8]). Similarly,
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both m.10680G > A and primary mutation m.14484T >
C which expressed complete penetrance. These two stu-
dies suggested that m.10680G > A played an active role
in LHON and might be a “suspected” pathogenic LHON
mutation. In order to investigate the frequency of
m.10680G > A in Chinese patients with clinical LHON
features but without any known mutations, we screened
this mutation in 774 suspected LHON patients by using
the allele specific PCR (AS-PCR). Our analysis of the
complete mtDNA genomes of the probands with muta-
tion m.10680G > A suggested that this mutation should
be regarded as a rare pathogenic mutation for LHON in
Chinese.
Materials and methods
Patients
The patients were physically evaluated and collected at
the Pediatric and Genetic Clinic of the Eye Hospital,
Zhongshan Ophthalmic Center and/or other local clinical
centers. All patients were subjected to acute or sub-acute
vision loss and lacked the three known LHON primary
mutations. We have sequenced the mtDNA control
region sequence and classified these patients with sus-
pected LHON into respective haplogroup and found no
haplogroup was associated with suspected LHON [17].
Because we used up DNA samples for some patients
during that study, only 774 out of 843 patients with
suspected LHON [17] were analyzed here. All these 774
patients were confirmed to harbor none of the four
LHON primary mutations (m.3460G > A, m.3635G > A,
m.11778G > A, and m.14484T > C). Informed consents
conforming to the tenets of the Declaration of Helsinki
were obtained from each participant prior to the study.
The institutional review boards of Zhongshan Ophthal-
mic Center and Kunming Institute of Zoology approved
this study.
Detection of mutation m.10680G > A
Mutation m.10680G > A was genotyped by using the AS-
PCR in 774 suspected LHON patients. The primer pair for
AS-PCR (L10680A: 5’-AGTCTTTGCCGCCTGCGATA-
3’/H10972: 5’-TCAGGTAGTTAGTATTAGGAG-3’) was
designed according to the strategy described in Bi et al.
[18]. Another primer pair L4887 (5’-TGACAAAAAC-
TAGCCCCCATCT -3’)/H5442 (5’-GCGATGAGTGTGG
GGAGGAA-3’) was used as the internal control for moni-
toring successful amplification during the AS-PCR. PCR
was performed in a total volume of 20 μLc o n t a i n i n g
30 ng DNA, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl2,
50 mM KCl, 0.5 units of TaKaRa rTaq, 175 μM of each
dNTP, and 0.3 μM of each primer. The amplification con-
dition for AS-PCR is composed of one denaturation cycle
at 94°C for 3 min, 30 cycles of denaturation at 94°C for
20 s, annealing at 61°C for 20 s, and extension at 72°C for
30 s, and one final extension cycle at 72°C for 5 min. In
order to evaluate the sensitivity of the AS-PCR in detect-
ing the minimum level of heteroplasmic mutation
m.10680G > A, five different concentrations of genomic
DNA of patient Le1263 with m.10680G > A (1 ng, 2.5 ng,
5 ng, 10 ng, and 15 ng) was used for amplification. In addi-
tion, DNA samples from patient Le1263 and a healthy
donor without m.10680G > A were mixed to achieve final
proportions of mutant DNA of 5%, 10%, and 20%, and a
total of 30 ng of mixed DNA was amplified. The sensitivity
is defined to be the smallest percentage of mutant DNA
that can be detected by the AS-PCR method. PCR pro-
ducts were separated on 1.5% agarose gel at 120 V for
30 min.
Analysis of the entire mtDNA genome for patients with
m.10680G > A
The entire mitochondrial genomes of probands with
m.10680G > A were amplified and sequenced by using
primers and methods described in our previous study
[19]. Sequences were handled by the DNASTAR pro-
g r a m( D N A SI n c ,M a d i s o n ,W I ,U S A ) .W ec l a s s i f i e d
each patient into accurate haplogroup relative to the
updated East Asian mtDNA tree and PhyloTree [20-22].
The novelty of variants/mutations was defined according
to the available guidelines described by Bandelt et al.
[23]. We presented mtDNA sequence variations in pro-
bands sequenced in this study, together with two
reported LHON mtDNAs with m.10680G > A (family
Le1107 reported by Zou et al. [15] and LHON family
reported by Yang et al. [16]) in a mtDNA tree. This
phylogenetic approach has been demonstrated to be
powerful to recognize private variants and haplogroup-
specific variants in each lineage [23]. Evolutionary con-
servation analysis of m.10680G > A was performed by
using the MitoTool (http://www.mitotool.org) [24].
To discern the frequency of m.10680G > A in
reported mtDNAs across world, we collected 9277 com-
plete (and/or incomplete) mtDNA sequences from Phy-
loTree (mtDNA Tree Build 12, 20 Jul 2011) [21] and
the MitoTool data set [24] and excluded those data of
Chinese LHON patients. The ten reported Chinese
patients with suspected LHON in our recent study [15]
were aggregated with the patients screened in this study.
Two tailed Fisher Exact test was used to evaluate the
difference of m.10680G > A frequency between Chinese
patients with suspected LHON and the reported data. A
P value less than 0.05 was considered as significant.
Results
Optimization of the AS-PCR for detecting m.10680G > A
As demonstrated in Figure 1A, two bands could be
amplified by using the allele-specific primer pair
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internal control primer pair L4887/H5442 (product
length is 596 bp) in the presence of mutation m.10680G
> A. This AS-PCR approach had a relatively high sensi-
tivity: 1) the specific band for m.10680G > A could be
well recognized when 10 ng DNA was used, despite the
fact that DNA template of 5 ng could also yield a weak
target band; 2) we could detect m.10680G > A when it
had a proportion of mutant DNA of 10% of total DNA
template (Figure 1B).
Clinical data and frequency of m.10680G > A in patients
with suspected LHON
We identified two patients (Le1263 and Le1330) with
homoplasmic mutation m.10680G > A in 774 patients
analyzed by the AS-PCR. Patient Le1263 is a 47 year-old
man from Guangdong Province and has no self-reported
family history of disease. He had felt an acute vision loss
in both eyes for 33 days when he came to hospital. His
best visual acuity is 0.2 for the right eye and 0.1 for the left
eye at the time of his visit to our clinic. Fundus observa-
tion revealed mild pale of the optic disc in the right eye
and mild edema of the optic disc with enlarged retinal ves-
sels in the left eye. He had normal cornea, lens, and intrao-
cular pressure (8 mmHg for the right eye and 11 mmHg
for the left eye). Patient Le1330 is a 19 year-old man from
Sichuan Province and has a family history of disease
(Figure 2). He had acute vision loss for both eyes about 5
years ago. Ocular examination revealed pale temporal disc.
Five other maternal relatives in his family had acute bilat-
eral vision loss at around 30 years old (Figure 2), which is
consistent with a pattern of maternal inheritance.
The overall frequency of m.10680G > A in Chinese
patients with suspected LHON was considerably low
(0.26% = 2/774), although this frequency was significantly
higher than that of the complied mtDNA data set for
world populations (0/9277) (P = 0.006). When we
included ten suspected LHON patients with family
Figure 1 Optimization of the allele-specific PCR method for detecting m.10680G > A. The DNA template of proband Le1263 was diluted
to have different concentrations with 1 ng, 2.5 ng, 5 ng, 10 ng, and 15 ng, respectively, to determine the smallest concentration of genomic
DNA that could be detectable by the AS-PCR method. Normal controls were confirmed to lack mutation m.10680G > A. Patients Le1263, Le1330
(this study) and Le1107 in our previous study [15] harbored mutation m.10680G > A (A). Genomic DNA templates of patient Le1263 and normal
control #1 were mixed to reach different proportions of mutant DNA. The percentage of mutated DNA stepwise from 5% to 20% (the mid-
concentration is 10%), to determine the smallest percentage of mutant DNA (B). PCR products were separated on 1.5% agarose gel. The upper
band (596 bp) is the internal control and the lower band (312 bp) indicates the presence of mutation m.10680G > A.
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total frequency increased to 0.38% (3/784) (compared to
the complied mtDNA data, P = 0.0005). A web-based
search and database search [23] showed that mutation
m.10680G > A only occurred in Chinese LHON patients.
The penetrance of LHON in family Le1330 was relatively
high (6/14 = 42.9%), similar to the reported family
Le1107 (8/20 = 40.0%) in our previous study [15]. All
these results suggest that the rare mtDNA mutation
m.10680G > A participates in the pathogenesis of LHON
in Chinese.
Multiple occurrence of m.10680G > A in different Chinese
mtDNA lineages
Analysis for the complete mtDNA genomes of the two
patients with m.10680G > A suggested that Le1263 and
Le1330 belonged to haplogroups B4a1 and D6a1, respec-
tively (Sequence could be retrieved from GenBank via
accession numbers JN866824 and JN866825). Excluding
these haplogroup-specific variants and mutation m.10680G
> A, we found 11 private variants in Le1263 and 8 private
variants in Le1330. Most of these private variants were
synonymous or were located in the non-coding region. No
“confirmed” or “suspected” LHON-associated mutation
(which was listed in MITOMAP database: http://www.
mitomap.org/bin/view.pl/MITOMAP/MutationsLHON)
was found in these two patients (Figure 3 and Table 1).
One non-synonymous variant in the MT-ND1 gene
(m.3548T > C, p.I81T) and one variant in the MT-RNR2
gene (m.2352T > C) were found in patient Le1263, whereas
patient Le1330 had two missense variants in the MT-ND1
gene (m.3745G > A, p.A147T) and the MT-ND5 gene
(m.13327A > G, p.T331A). Except for variant m.2352T >
C, the other three non-synonymous variants had a consid-
erably high conservation index (CI) (> 0.8) (Table 1), sug-
gesting these positions being evolutionarily conserved. All
these private variants have been reported in the general
populations, and variant m.3548T > C has been previously
reported in patients with LHON [25] and diabetes [26].
Discussion
Though over 95% LHON patients was affected by one of
the three primary mutations, the etiological factor of the
remaining 5% LHON patients was unclear [1-3]. Many
sporadic cases without three primary mutations have
been reported and mtDNA mutations identified in these
lineages were considered as pathogenic, despite the fact
that the exact pathogenicity remains to be proved by
functional assays. The spectra of the LHON primary
mutations showed remarkabled i f f e r e n c eb e t w e e nE u r -
opean patients and Chinese patients [8,9,28-30], we
s p e c u l a t e dt h a tt h e r em i g h tb es o m em o r ep a t h o g e n i c
mtDNA mutations that were unique to Chinese LHON
patients.
Figure 2 Pedigree of LHON family Le1330 with m.10680G > A. Filled symbols represent affected individuals with LHON. The proband that
was analyzed for the complete mtDNA sequence was marked by an arrow.
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Page 4 of 8Figure 3 Classification tree of four mtDNAs with m.10680G > A. Two reported LHON mtDNAs (Le1107 [15] and FJ986465 [16]) were
adopted from published sources. The revised Cambridge reference sequence (rCRS) [27] was included to show the phylogenetic relationship of
the lineages and haplogroup-specific variants. The order of variants on each uninterrupted branch section is arbitrary. Haplogroup names were
placed on each branch to show their hierarchical and nested positions within macrohaplogroups M and N. Recurrent variants were underlined.
Deletion of nucleotide(s) was indicated by suffix “d”. Length mutations of the C-tract in region 303-309 were omitted from the tree. Mutation
m.10680G > A was marked in boldfaced. The synonymous and non-synonymous coding-region variants in these mtDNAs were further denoted
by “/s” and “/ns”, respectively. Variations in the ribosomal RNA genes and tRNA genes were denoted by “/r” and “/t”, respectively.
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tion m.10680G > A in 774 Chinese patients with suspected
LHON and found two patients harboring this mutation.
Our approach had a reasonably good sensitivity in detect-
ing minimum level of mutant DNA of 10% of total DNA
template ≥ 10 ng). Compared to other approaches, such as
sequencing, single-strand conformation polymorphism
(SSCP), and restriction fragment length polymorphism
(RFLP), the AS-PCR method is fast and cost-effective and
can be of potential usage in the clinic for fast screening of
mutation m.10680G > A in patients with suspected
LHON. We did not identify any heteroplasmy of mutation
m.10680G > A in the two patients with m.10680G > A in
this study and patient Le1107 in our previous study [15]
based on the limitation of detection sensitivity of our AS-
PCR and direct sequencing approach. Though we did not
design an allele-specific PCR (or a PCR-RFLP method) to
detect the minimum level of wild-type allele in these
patients to double check for heteroplasmy, the overall pat-
tern was consistent with our previous observation for a
very low frequency of heteroplasmic m.11778G > A (1/479
= 0.21%; Ref. [17]) and m.14484T > C (3/52 = 5.8%; Ref.
[30]) in Han Chinese patients. As m.10680G > A creates a
digestion site for enzyme TseI, we could also use PCR-
RFLP method to screen this mutation and measure the
level of heteroplasmy. One limitation is that enzyme TseI
is quite expensive and this PCR-RFLP method is not cost-
effective and time-consuming in clinic.
The frequency of m.10680G > A in Chinese LHON
patients was slightly lower than that of primary mutation
m.3635G > A [7]. Although the conservation index (0.84)
of p.A71T (m.10680G > A) was not as high as one would
expect for a pathogenic mutation, it would affect the sec-
ondary or tertiary structure of the ND4L subunit (Figure 4).
The alanine to threonine change at the 71
st amino acid
position is next to E70, one of the two highly conserved
glutamates in transmembrane helices of the ND4L protein,
and those glutamates have been shown to be essential for
enzyme activity [31]. Moreover, the two glutamates within
transmembrane helices of nuoK/ND4L have been recently
considered to be linked to the proton pumping function of
complex I (NADH:ubiquinone oxidoreductase) in light of
the recently revealed spatial structure of the membrane
arm of complex I in E. coli [32,33]. Therefore, there indeed
seem to be reasons for the pathogenicity of mutation
m.10680G > A.
A web-based and database search showed that mutation
m.10680G > A has been independently reported to affect
LHON in two Chinese families [15,16]. These two
reported patients belonged to haplogroups M13a [15]
and B4d [16] (Figure 3). Therefore, it seemed that muta-
tion m.10680G > A occurred only in Chinese LHON
patients and had a multiple occurrence in different
mtDNA background. In the Chinese family reported by
Yang et al. [16], m.10680G > A coexisted with primary
mutation m.14484T > C, and the presence of both muta-
tions caused complete penetrance of LHON. In the two
families with m.10680G > A reported in this study and
our previous study [15], we found that the penetrance of
LHON (> 40%) was even higher than those families with
m.11778G > A (33.3%; Ref. [8]), m.14484T > C (31.9%;
Ref. [30]) or m.3460G > A (25.6%; Ref. [29]). Patient
Le1263 was self-reported as sporadic and his family was
not considered to calculate the penetrance. Note that our
estimation for disease penetrance for m.10680G > A was
based on two families, which might lead to a bias.
Analysis for the entire mtDNA genomes of the two
patients with m.10680G > A identified in this study
showed that they harbored no novel or “confirmed” patho-
genic mutation. However, variant m.3548T > C was found
in patient Le1263, which is located in the mutational hot-
spot (MT-ND1 gene) for Chinese patients with LHON but
lacking three known primary mutations [15] and was also
reported in another LHON patient [25], whether m.3548T
> C had a synergistic effect with m.10680G > A to influ-
ence disease expression in Le1263 was not clear, as we
lacked necessary clinical information and this patient had
no self-reported family history of disease. Similarly, two
private variants were found in patient Le1330, which were
located in the MT-ND1 and MT-ND5 genes (Table 1),
further supported our previous claim that the MT-ND1
and MT-ND5 genes are mutational hotspots for Chinese
families with clinical features of LHON but lacking the
three primary mutations [15].
Conclusion
In summary, we designed an AS-PCR method for rapid
screening of m.10680G > A in a large cohort of Chinese
Table 1 Private mtDNA variants in two Chinese probands with m.10680G>A
Sample Nucleotide variant (Amino acid change) Gene CI
a Population report
b Disease report
b
Le1263 m.3548T > C (p.I81T) MT-ND1 0.907 Yes Yes
m.2352T > C MT- RNR2 0.047 Yes No
Le1330 m.13327A > G (p.T331A) MT-ND5 0.837 Yes No
m.3745G > A (p.A147T) MT-ND1 0.884 Yes No
a Conservation index (CI) was estimated by using 43 primate species according to the MitoTool [24].
b The search was performed on Oct 31, 2011 following the same strategy described earlier [23] (e.g. both ‘T3548C mtDNA’ and ‘m.3548T > C mtDNA’ were
queried).
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nese subjects with m.10680G > A. Analysis of the com-
plete mtDNA sequences of the two probands and
combining with information of two reported cases
[15,16], we proposed that m.10680G > A is a rare patho-
genic mutation in Chinese LHON population. Further
functional assays, e.g. respiration measurements and
NADH:ubichinon oxidoreductase activity assays in
patient fibroblasts and eventually in newly constructed
cybrid cell lines harbouring the mutation, should be car-
ried out and more families with m.10680G > A should
be included to validate our conclusion.
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